Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (78) Depakote (divalproex sodium), Abbott Laboratories,
...Newly Approved Drug Therapies (78) Depakote (divalproex sodium), Abbott Laboratories, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Depakote (divalproex sodium) Company: Abbott Laboratories Approval Status: Approved March 1996 Treatment Area: migraine headaches General Information ...
View Page

2.  Newly Approved Drug Therapies (636) Depakote ER (divalproex sodium), Abbott Laboratories,
...Newly Approved Drug Therapies (636) Depakote ER (divalproex sodium), Abbott Laboratories, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Depakote ER (divalproex sodium) Company: Abbott Laboratories Approval Status: Approved August 2000 Treatment Area: For the prophylaxis (prevention ...
View Page

3.  Newly Approved Drug Therapies (133) Depakote (divalproex sodium), Abbott Laboratories,
...Newly Approved Drug Therapies (133) Depakote (divalproex sodium), Abbott Laboratories, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Depakote (divalproex sodium) Company: Abbott Laboratories Approval Status: Approved June 1996 Treatment Area: epilepsy General Information Depakote ...
View Page

4.  Study Posting (2348) Trial #43221, Leukemia, New York, NY
...Trial #43221, Leukemia, New York, NY Trial Information A Phase I-II Pilot Study of Divalproex Sodium and All-Trans-Retinoic Acid (ATRA) in Relapsed or Refractory Acute Myeloid Leukemia (except ...
...FAB Classification) The purpose of this research study is to: 1) determine the safety of divalproex sodium alone and in combination with ATRA in the treatment of Acute Myeloid Leukemias (AML ...
View Page

5.  Study Posting (2467) Trial #155548, Bipolar Disorders, Lake Charles, LA
...blind, placebo controlled, fixed flexible dose, parallel group study of lurasidone adjunctive to lithium or divalproex for treatment of Bipolar I depression Blind, placebo controlled, fixed flexible dosing of lurasidone for ...
...with or without rapid cycling and without psychotic features with adjunctive therapy to lithium or divalproex Patient Inclusion Criteria: • 18-75 years of age • Lifetime history of bipolar I disorder, most ...
View Page

6.  Study Posting (4971) Trial #161600, Alcohol Dependence, Maitland, FL
...are prohibited during this study: acamprosate, all anxiolytics, all antidepressants, baclofen, benzodiazepines, buprenorphine, carbamazepine, disulfiram, divalproex sodium, ethosuximide, felbamate, gabapentin, lamotrigine, levetiracetam, levomethadyl acetate (LAAM), mephobarbital, methadone, methsuximide, naltrexone (any formulation ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (20), Bipolar Disorders
...clinical trial investigating Seroquel (quetiapine fumarate), in combination with traditional mood stabilization therapy (lithium or divalproex), on adolescents with bipolar disorder. The double blind, placebo-controlled, randomized clinical study evaluated the efficacy of Seroquel and divalproex as a combination therapy, versus divalproex alone, in 30 subjects ages 12 to 18. The ...
View Page

8.  CenterWatch: Otolaryngology Approved Drug Therapies
...and perennial allergic rhinitis and urticaria, Approved May 2007 Drugs Approved in 2000 Depakote ER (divalproex sodium) ; Abbott Laboratories; For the prophylaxis (prevention) of migraine headaches in adults, Approved August 2000 ...
View Page

9.  CenterWatch: Clinical Trials in Category (20) Bipolar Disorders
...blind, placebo controlled, fixed flexible dose, parallel group study of lurasidone adjunctive to lithium or divalproex for treatment of Bipolar I depression Lake Charles : Lake Charles Clinical Trials Randomized 6 week ...
View Page

10.  CenterWatch: Neurology Approved Drug Therapies
...treatment of acute migraine in adults, Approved February 2001 Drugs Approved in 2000 Depakote ER (divalproex sodium) ; Abbott Laboratories; For the prophylaxis (prevention) of migraine headaches in adults, Approved August 2000 ...
...August 1996 ARICEPT (donepezil hydrochloride) ; Eisai; Treatment for Alzheimer's Disease, Approved December 1996 Depakote (divalproex sodium) ; Abbott Laboratories; Treatment for epilepsy, Approved June 1996 Depakote (divalproex sodium) ; Abbott Laboratories; Treatment ...
View Page

11.  CenterWatch: List of Newly Approved Drug Thearapies
...August 1996 ARICEPT (donepezil hydrochloride) ; Eisai; Treatment for Alzheimer's Disease, Approved December 1996 Depakote (divalproex sodium) ; Abbott Laboratories; Treatment for migraine headaches, Approved March 1996 Depakote (divalproex sodium) ; Abbott Laboratories; Treatment for epilepsy, Approved June 1996 Iontocaine ; Iomed; Needle-free anesthetic, Approved ...
View Page

12.  Study Posting (466) Trial #157645, Migraine and Cluster Headaches, Providence, RI
...graded as groups 1, 2, 3, and 4 in the AAN Evidence-based Guideline: valproate, divalproex sodium, gabapentin, amitriptyline, nortriptyline, protriptyline, beta-blocker, calcium channel blocker, cyproheptadine; and tizanidine) within the ...
View Page

13.  Study Posting (466) Trial #157647, Migraine and Cluster Headaches, Bellingham, MA
...graded as groups 1, 2, 3, and 4 in the AAN Evidence-based Guideline: valproate, divalproex sodium, gabapentin, amitriptyline, nortriptyline, protriptyline, beta-blocker, calcium channel blocker, cyproheptadine; and tizanidine) within the ...
View Page

14.  Study Posting (466) Trial #157646, Migraine and Cluster Headaches, Pawcatuck, CT
...graded as groups 1, 2, 3, and 4 in the AAN Evidence-based Guideline: valproate, divalproex sodium, gabapentin, amitriptyline, nortriptyline, protriptyline, beta-blocker, calcium channel blocker, cyproheptadine; and tizanidine) within the ...
View Page

15.  CenterWatch Clinical Research Profile (2467) Trial #1199, Lake Charles Clinical Trials, Lake Charles, LA
...blind, placebo controlled, fixed flexible dose, parallel group study of lurasidone adjunctive to lithium or divalproex for treatment of Bipolar I depression • Randomized 6 week, double blind, placebo controlled, fixed flexible ...
View Page

16.  CenterWatch: New Medical Therapies in Disease Category (98), Manic Disorders
...mean of 500 mg of Seroquel or placebo while mood stabilizers such as lithium or divalproex were administered unblinded prior to randomization. The results indicated that 54% of subjects treated with ...
View Page

17.  CenterWatch: Psychiatry/Psychology Approved Drug Therapies
...February 1996 ARICEPT (donepezil hydrochloride) ; Eisai; Treatment for Alzheimer's Disease, Approved December 1996 Depakote (divalproex sodium) ; Abbott Laboratories; Treatment for migraine headaches, Approved March 1996 Lithobid (Lithium Carbonate) ; Solvay Pharmaceuticals ...
View Page

18.  CenterWatch: List of Newly Approved Drug Thearapies
...For pain relief in men with advanced prostate cancer, Approved March 2000 Neurology Depakote ER (divalproex sodium) ; Abbott Laboratories; For the prophylaxis (prevention) of migraine headaches in adults, Approved August 2000 ...
...treatment of wet age-related macular degeneration (wet AMD), Approved April 2000 Otolaryngology Depakote ER (divalproex sodium) ; Abbott Laboratories; For the prophylaxis (prevention) of migraine headaches in adults, Approved August 2000 ...
View Page

19.  CenterWatch: Clinical Trials in Category (92) Leukemia
...Leukemia - Adults New York : Mount Sinai Medical Center A Phase I-II Pilot Study of Divalproex Sodium and All-Trans-Retinoic Acid (ATRA) in Relapsed or Refractory Acute Myeloid Leukemia (except ...
View Page